Kriya gains $320m in Series D for gene therapy development
The capital is earmarked for the advancement of trials across various therapeutic domains.
Cytiva Pipe dream to pipeline WP 3
Kytopen and BlueWhale Bio partner for cell therapy innovation
MD Anderson and Phoenix to advance cell and gene therapy tech
FDA grants RMAT designation to Hope Biosciences’ MS treatment
ExCellThera gains EC authorisation for Zemcelpro cell therapy
Andelyn and Amplo link on AAV gene therapy for NMJ conditions
Apertura signs multiple licensing agreements for TfR1 CapX tech
Japan MHLW approves Biostar’s angel stem cell therapy for autism
